#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant central nervous system neoplasm Cold type haemolytic anaemia Iron overload Philadelphia positive acute lymphocytic leukaemia Glioblastoma multiforme Squamous cell carcinoma of the hypopharynx Acute promyelocytic leukaemia Atopic keratoconjunctivitis Necrotising myositis Emphysema Urea cycle disorder Renal cancer metastatic Meningitis meningococcal Mucopolysaccharidosis I Dementia with Lewy bodies More trials…

    Learn about Rare Diseases

    Gastrointestinal stromal tumour – Life with Disease Cytokine release syndrome – Treatment Leiomyosarcoma Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Immunodeficiency congenital – Treatment Hairy cell leukaemia recurrent – Life with Disease Systemic sclerosis pulmonary – Trials in Disease Encephalitis autoimmune – Treatment Haemophilia B without inhibitors – Life with Disease Langerhans’ cell histiocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Casirivimab Etrinabdione Berotralstat Deferiprone BENZYLPENICILLIN POTASSIUM Urea BIIB115 Pf-06480605 Brinzolamide Testosterone GLYCYL-TYROSINE Demeclocycline Hydrochloride SODIUM DIHYDROGEN PHOSPHATE Clobetasol Propionate Specific Nucleic Acid Sna-Ebv Aspergillus Fumigatus AZD4512 CICLOPIROX LUNRESERTIB Dydrogesterone More therapies…

    Learn about Your Condition

    Necrotising myositis Tooth loss Dry eye Habitual abortion Vestibular disorder Thalassaemia alpha Migraine with aura Gender dysphoria Onychomycosis Von Hippel-Lindau disease Osteotomy B-cell lymphoma recurrent Burning mouth syndrome Primary hyperaldosteronism Post-acute COVID-19 syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study of canagliflozin and 18F-canagliflozin in patients with chronic kidney disease undergoing dialysis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    Investigated Drugs:
    • [18F] CANAGLIFLOZIN
    • Canagliflozin
    The Netherlands

  • Comparing the effect of romosozumab and denosumab on coronary artery damage in women with postmenopausal osteoporosis

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Romosozumab
    • Denosumab
    Italy

  • A study to evaluate the effectiveness of upadacitinib and pirfenidone in reducing symptom severity in patients with Long Covid

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • Cellulose, Microcrystalline
    • Pirfenidone
    • Upadacitinib
    Italy

  • A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Sonelokimab
    Bulgaria Croatia Czechia Estonia Finland France +10

  • Study of the effectiveness and safety of alpha-lipoic acid and benfotiamine for the treatment of symptoms in patients with diabetic neuropathy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Diabetic neuropathy
    Investigated Drugs:
    • Benfotiamine
    Hungary

  • A study to evaluate if silymarin prevents liver damage caused by ribociclib in patients with hormone receptor positive, HER2-negative breast cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • SILYMARIN
    • Ribociclib
    Italy
Previous Page
1 … 739 740 741 742 743 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!